Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
Jubilant Ingrevia 14-Day RSI Related Terms
BOM:543271 vs LIN, SHW, ECL: 14-Day RSI Comparison
For the Specialty Chemicals subindustry, Jubilant Ingrevia's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jubilant Ingrevia 14-Day RSI vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Jubilant Ingrevia's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where Jubilant Ingrevia's 14-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jubilant Ingrevia (BOM:543271) has a 14-Day RSI of 39.99 as of Sep. 04, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Jubilant Ingrevia and its competitors. According to the industry distribution chart, Jubilant Ingrevia ranks #236 out of 1653 companies in the Chemicals industry, placing it in the top 14.3%.
Is Jubilant Ingrevia's 14-Day RSI too high?
Jubilant Ingrevia's current 14-Day RSI is 39.99. The Chemicals industry median 14-Day RSI is 50.13. Jubilant Ingrevia's value of 39.99 is 20.2% below this industry median. Based on the distribution chart, Jubilant Ingrevia ranks #236 out of 1653 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Jubilant Ingrevia has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Jubilant Ingrevia's 14-Day RSI compare to LIN and SHW?
According to the Chemicals industry distribution chart, Jubilant Ingrevia ranks #236 out of 1653 companies for 14-Day RSI. This places Jubilant Ingrevia in the top 14% of its industry — outperforming the majority of peers. The industry median 14-Day RSI is 50.13. Jubilant Ingrevia's value of 39.99 is 20.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Chemicals company?
The median 14-Day RSI among Chemicals companies is 50.13, based on 1,653 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jubilant Ingrevia's current 14-Day RSI of 39.99 is 20.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Jubilant Ingrevia and its competitors. For the Chemicals industry, the median 14-Day RSI is 50.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jubilant Ingrevia's current 14-Day RSI is 39.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jubilant Ingrevia stock overvalued right now?
Based on GuruFocus' analysis, Jubilant Ingrevia (BOM:543271) is currently considered Fairly Valued. The stock's GF Value™ is ₹759.38, compared to a current price of ₹690.00 — trading 9.1% below its estimated fair value. The current 14-Day RSI is 39.99 and 20.2% below the Chemicals industry median of 50.13. Jubilant Ingrevia's overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For Jubilant Ingrevia (BOM:543271), the current 14-Day RSI is 39.99 as of Sep. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jubilant Ingrevia (BOM:543271) Overvalued in 2026?
Based on GuruFocus' analysis, Jubilant Ingrevia stock appears to be undervalued.
The current stock price of ₹690.00 is trading 9.1% below its estimated GF Value™ of ₹759.38.
GuruFocus considers Jubilant Ingrevia to be Fairly Valued.
Key valuation signals for BOM:543271:
14-Day RSI: 39.99
GF Value™: ₹759.38 vs. price of ₹690.00 (9.1% below fair value)
Industry Position: 20.2% below the Chemicals median (#236 of 1653)
No single metric tells the full story. See the BOM:543271 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jubilant Ingrevia Ltd is a life science products and solutions provider in the chemicals industry. It serves Pharmaceutical, Nutrition, Agrochemical, Consumer, and Industrial customers with its customized products and solutions. Its segments are Specialty chemicals, Nutrition & Health solutions, and Chemical Intermediates. The maximum revenue for the company is generated from its Specialty chemicals segment, which includes Bio-Pyridine & Bio-Picolines, Fine chemicals, Agro chemicals, Custom development and manufacturing organization, Microbial control solutions.. Geographically, it derives key revenue from India and the rest from the Americas and Europe, China, and the Rest of the world.
82GF Score
Get the complete analysis for BOM:543271
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543271 has been successfully added to your 
